Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Harris

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Therapeutics|December 1, 2015
Effects of Paroxetine,a CYP2D6 Inhibitor, on the Pharmacokinetic Properties of Hydrocodone After Coadministration With a Single-entity,Once-daily, Extended-release HydrocodoneTabletRam P Kapil, Kristen Friedman, Alessandra Cipriano, et al.
Clinical Therapeutics|September 10, 2015
Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tabletRam P Kapil, Kristen Friedman, Alessandra Cipriano, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2009
ArrayTrack: an FDA and public genomic toolHong Fang, Stephen C Harris, Zhenjiang Su, et al.
Journal of Clinical Pharmacology|August 14, 2013
Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tabletsDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2017
ArrayTrack: An FDA and Public Genomic ToolHong Fang, Stephen C Harris, Zhenjiang Su, et al.
Pain Medicine (Malden, Mass.)|September 22, 2016
Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid UsersStephen C Harris, Alessandra Cipriano, Salvatore V Colucci, et al.
Clinical Therapeutics|January 11, 2016
Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent PropertiesRam P Kapil, Alessandra Cipriano, Warren Wen, et al.
Pain Medicine (Malden, Mass.)|January 28, 2016
Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid UsersStephen C Harris, Alessandra Cipriano, Salvatore V Colucci, et al.
Journal of Clinical Psychopharmacology|March 23, 2026
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) ReceptorsStephen C Harris, Alessandra Cipriano, Garth T Whiteside, et al.
Frontiers in Pharmacology|September 3, 2024
Evaluation of sunobinop for next-day residual effects in healthy participantsAlessandra Cipriano, Ram P Kapil, Mingyan Zhou, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Therapeutics|December 1, 2015
Effects of Paroxetine,a CYP2D6 Inhibitor, on the Pharmacokinetic Properties of Hydrocodone After Coadministration With a Single-entity,Once-daily, Extended-release HydrocodoneTabletRam P Kapil, Kristen Friedman, Alessandra Cipriano, et al.
Clinical Therapeutics|September 10, 2015
Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tabletRam P Kapil, Kristen Friedman, Alessandra Cipriano, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2009
ArrayTrack: an FDA and public genomic toolHong Fang, Stephen C Harris, Zhenjiang Su, et al.
Journal of Clinical Pharmacology|August 14, 2013
Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tabletsDavid J Greenblatt, Jerold S Harmatz, Nikhilesh N Singh, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2017
ArrayTrack: An FDA and Public Genomic ToolHong Fang, Stephen C Harris, Zhenjiang Su, et al.
Pain Medicine (Malden, Mass.)|September 22, 2016
Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid UsersStephen C Harris, Alessandra Cipriano, Salvatore V Colucci, et al.
Clinical Therapeutics|January 11, 2016
Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent PropertiesRam P Kapil, Alessandra Cipriano, Warren Wen, et al.
Pain Medicine (Malden, Mass.)|January 28, 2016
Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid UsersStephen C Harris, Alessandra Cipriano, Salvatore V Colucci, et al.
Journal of Clinical Psychopharmacology|March 23, 2026
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) ReceptorsStephen C Harris, Alessandra Cipriano, Garth T Whiteside, et al.
Frontiers in Pharmacology|September 3, 2024
Evaluation of sunobinop for next-day residual effects in healthy participantsAlessandra Cipriano, Ram P Kapil, Mingyan Zhou, et al.
Pageof 4